Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 5
2003 5
2004 7
2005 3
2006 6
2007 10
2008 7
2009 4
2010 8
2011 4
2012 6
2013 9
2014 12
2015 10
2016 5
2017 5
2018 18
2019 4
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

117 results
Results by year
Filters applied: . Clear all
Page 1
Chronic Hepatitis B Increases Liver-Related Mortality of Patients With Acute Hepatitis E: A Territorywide Cohort Study From 2000 to 2016.
Lai JC, et al. Clin Infect Dis 2018. PMID 30265321
BACKGROUND: The epidemiology of acute hepatitis A and E has been changing over the last 2 decades. The impact of concomitant chronic hepatitis B (CHB) on clinical outcomes remains unclear. ...CONCLUSIONS: The mortality is higher in patients with acute hepatitis E than in those with hepatitis A. Coexisting CHB is the independent risk factor for liver-related mortality in patients with acute hepatitis E....
BACKGROUND: The epidemiology of acute hepatitis A and E has been changing over the last 2 decades. The impact of concomitant chron
[Mortality due to chronic viral hepatitis B and C infections in the Netherlands].
Hofman R, et al. Ned Tijdschr Geneeskd 2016. PMID 27734776 Dutch.
OBJECTIVE: To estimate mortality due to chronic hepatitis B-virus (HBV) and hepatitis C-virus (HCV) infections in the Netherlands from 2002 to 2015. ...HCC mortality due to viral hepatitis was higher in Dutch people of non-western origin. CONCLUSION: Mortality from chronic viral hepatitis is mostly the result of cirrhosis of the liver and HCC. ...
OBJECTIVE: To estimate mortality due to chronic hepatitis B-virus (HBV) and hepatitis C-virus (HCV) infec …
Chronic hepatitis B increases mortality and complexity among HIV-coinfected patients in South Africa: a cohort study.
Velen K, et al. HIV Med 2016. PMID 26991340 Free PMC article.
OBJECTIVES: To assess the effect of chronic hepatitis B on survival and clinical complexity among people living with HIV following antiretroviral therapy (ART) initiation. METHODS: We evaluated mortality and single-drug substitutions up to 3 years from ART initiation (median follow-up 2.75 years; interquartile range 2-3 years) among patients with and without chronic hepatitis B (CHB) enrolled in a workplace HIV care programme in South Africa. ...
OBJECTIVES: To assess the effect of chronic hepatitis B on survival and clinical complexity among people living with HI …
Eight-year survival in chronic hepatitis B patients under long-term entecavir or tenofovir therapy is similar to the general population.
Papatheodoridis GV, et al. J Hepatol 2018 - Clinical Trial. PMID 29427727
BACKGROUND & AIMS: The effects of long-term antiviral therapy on survival have not been adequately assessed in chronic hepatitis B (CHB). ...HCC is the main factor affecting their overall mortality, and is the only factor affecting their liver-related mortality. LAY SUMMARY: Caucasian patients with chronic hepatitis B with or without compensated cirrhosis who receive long-term entecavir or tenofovir therapy have excellent overall eight-year survival, which is similar to that of the general population. ...
BACKGROUND & AIMS: The effects of long-term antiviral therapy on survival have not been adequately assessed in chronic hepatit
Past exposure to hepatitis B: a risk factor for increase in mortality?
Jinjuvadia R, et al. J Clin Gastroenterol 2014. PMID 23751854 Free PMC article.
BACKGROUND: Chronic hepatitis B has been shown to increase mortality, but association of past exposure to hepatitis B and mortality has not been studied well. ...The overall mortality from past exposure to hepatitis B was assessed in participants without any chronic liver diseases (CLD) and in participants with chronic hepatitis C, alcoholic liver disease (ALD), and nonalcoholic fatty liver disease. ...
BACKGROUND: Chronic hepatitis B has been shown to increase mortality, but association of past exposure to hep
Monitoring response to hepatitis B and C in EU/EEA: testing policies, availability of data on care cascade and chronic viral hepatitis-related mortality - results from two surveys (2016).
Aspinall EJ, et al. HIV Med 2018. PMID 29488708 Free article.
The two surveys covered (A) availability of policy documents on testing; testing practices and monitoring; monitoring of diagnosis and treatment initiation, and; (B) availability of data on mortality attributable to chronic viral hepatitis. ...Corresponding figures for HCV were 48% (10/21) and 57% (12/21). 27% (6/22) of countries reported availability of data on mortality attributable to chronic viral hepatitis. ...
The two surveys covered (A) availability of policy documents on testing; testing practices and monitoring; monitoring of diagnosis and treat …
Capacity to report on mortality attributable to chronic hepatitis B and C infections by Member States: An exercise to monitor progress towards viral hepatitis elimination.
Duarte G, et al. J Viral Hepat 2018. PMID 29479771
Viral hepatitis is globally leading causes of death, and 96% of these are due to hepatitis B and C (HBV/HCV) late outcomes. The first Global Health Sector Strategy (GHSS) aims to reduce by 65% the mortality associated with HBV/HCV, and an indicator (C10) is proposed to monitor progress. Data on viral hepatitis and liver-related mortality are required, and different methods of estimation can be used, depending on availability and quality of sources. ...
Viral hepatitis is globally leading causes of death, and 96% of these are due to hepatitis B and C (HBV/HCV) late outco …
Serum alanine aminotransferase level and liver-related mortality in patients with chronic hepatitis B: A large national cohort study.
Shim JJ, et al. Liver Int 2018. PMID 29377574
BACKGROUND: The serum alanine aminotransferase (ALT) level has been used to identify at-risk patients with chronic hepatitis B (CHB) who need antiviral therapy. ...In patients with ALT levels of 40-79 U/L, the liver-related mortality rates were 0.60% in men and 0.64% in women, which were similar to the overall mortality rate of age- and sex-matched subjects without CHB (0.69%). ...
BACKGROUND: The serum alanine aminotransferase (ALT) level has been used to identify at-risk patients with chronic hepatitis
Changing Trends in Etiology-Based Annual Mortality From Chronic Liver Disease, From 2007 Through 2016.
Kim D, et al. Gastroenterology 2018. PMID 30009816 Free PMC article.
Mortality related to hepatitis B virus decreased steadily from 2007 through 2016, with an average APC of -2.1% (95% CI -3.0 to -1.2). ...Non-Hispanic Asians had higher mortality for hepatitis B virus infection (2.82 per 100,000 vs 1.02 for non-Hispanic blacks and 0.47 for non-Hispanic whites). ...
Mortality related to hepatitis B virus decreased steadily from 2007 through 2016, with an average APC of -2.1% (95% CI
Mortality associated with hepatitis C and hepatitis B virus infection: A nationwide study on multiple causes of death data.
Fedeli U, et al. World J Gastroenterol 2017 - Clinical Trial. PMID 28348493 Free PMC article.
AIM: To analyze mortality associated with hepatitis C virus (HCV) and hepatitis B virus (HBV) infection in Italy. METHODS: Death certificates mentioning either HBV or HCV infection were retrieved from the Italian National Cause of Death Register for the years 2011-2013. ...CONCLUSION: Population ageing, immigration, and new therapeutic approaches are shaping the epidemiology of virus-related chronic liver disease. ...
AIM: To analyze mortality associated with hepatitis C virus (HCV) and hepatitis B virus (HBV) infection in Italy …
117 results
Jump to page
Feedback